clodronic acid has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benner, A; Dürr, C; Egle, A; Gribben, JG; Hanna, BS; Kalter, V; Lichter, P; McClanahan, F; Rößner, PM; Seiffert, M; Yazdanparast, H; Zaborsky, N | 1 |
Anselmo, A; Barbaglio, F; Bertilaccio, MTS; Caligaris-Cappio, F; Cittaro, D; Corti, A; De Palma, M; Galletti, G; Ghia, P; Klein, C; Lazarevic, D; Ponzoni, M; Ranghetti, P; Riba, M; Ries, CH; Rocchi, M; Rodriguez, TV; Scarfò, L; Scielzo, C; Simonetti, G; van Rooijen, N | 1 |
2 other study(ies) available for clodronic acid and B-Cell Chronic Lymphocytic Leukemia
Article | Year |
---|---|
Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo.
Topics: Animals; Antigens, Ly; B7-H1 Antigen; Chemokine CXCL9; Clodronic Acid; Dendritic Cells; Disease Models, Animal; Gene Expression Regulation, Leukemic; Humans; Immunophenotyping; Interleukin-10; Leukemia, Lymphocytic, Chronic, B-Cell; Macrophages; Mice; Mice, Transgenic; Monocytes; Peritoneal Cavity; Phenotype; Receptors, CCR2; Signal Transduction; Spleen; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2016 |
Targeting Macrophages Sensitizes Chronic Lymphocytic Leukemia to Apoptosis and Inhibits Disease Progression.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; B-Lymphocytes; Cell Communication; Cell Line, Tumor; Clodronic Acid; Disease Progression; Gene Expression Regulation, Leukemic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Liposomes; Macrophages; Mice; Mice, Transgenic; Neoplasm Transplantation; Primary Cell Culture; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Signal Transduction; Survival Analysis; Transplantation, Heterologous; Tumor Microenvironment | 2016 |